Evidence map›Paper›PMID 42750013›Full record

ArticleBMC infectious diseases2026

Comment on: Changes in microbiological characteristics of bloodstream infections before and after the COVID-19 pandemic in a tertiary teaching hospital in Iran.

Sebastiana Silva Sabino, Alexia Máximo Fernandes, Natália Ludendorff Queiroz, Cristiane Silveira de Brito, Lícia Ludendorff Queiroz, Celsa Raquel Villaverde Melgarejo, Paulo P Gontijo Filho, Rosineide Marques Ribas

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sebastiana Silva SabinoGraduate Program in Immunology and Applied Parasitology, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Alexia Máximo FernandesFaculty of Medicine, Federal University of Uberlândia, Residency in Obstetric Nursing, Uberlândia, Minas Gerais, Brazil.
Natália Ludendorff QueirozGraduate Program in Immunology and Applied Parasitology, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Cristiane Silveira de BritoLaboratory of Molecular Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Lícia Ludendorff QueirozLaboratory of Molecular Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Celsa Raquel Villaverde MelgarejoGraduate Program in Immunology and Applied Parasitology, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Paulo P Gontijo FilhoLaboratory of Molecular Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
Rosineide Marques RibasLaboratory of Molecular Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. rosi_ribas@yahoo.com.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This correspondence comments on study published in this journal investigating bloodstream infection microbiology before and during the COVID-19 pandemic in Iran, contextualized with Brazilian intensive care data: 44.5% developed microbiologically confirmed secondary infections, Gram-negative pathogens predominated, antibiotic resistance reached 79.4%, supporting stronger antimicrobial stewardship globally through coordinated surveillance efforts urgently.

Indexed as

BacteremiaCOVID-19Anti-Bacterial AgentsCross InfectionHospitals, TeachingHumansIranPandemicsTertiary Care CentersAnti-Bacterial AgentsAntibiotic useCOVID-19Healthcare-associated infectionsMultidrug resistanceSecondary infection

Identifiers

PMID42750013
PMCPMC13584543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.